United States Minimally Invasive Surgery Market to Reach US$ 35.3 Billion by 2032, Fueled by Increasing Prevalence of Chronic Diseases

According to the latest report by IMARC Group, titled “­­United States Minimally Invasive Surgery Market Report by Product Type (Surgical Devices, Laparoscopy Devices, Monitoring and Visualization Devices), Application (Bariatric Surgery, Breast Surgery, Cardiac Surgery, Cosmetic Surgery, Gastrointestinal Surgery, Gynaecological Surgery, Orthopedics and Spine Surgery, Thoracic Surgery, and Others), End User (Hospitals, Clinics, and Others), and Region 2024-2032,” the United States minimally invasive surgery market size reached US$ 24.7 Billion in 2023. Minimally invasive surgery (MIS) utilizes advanced techniques to perform procedures with minimal damage to surrounding tissues. Compared to traditional open surgeries that require large incisions, MIS employs specialized instruments, such as laparoscopes and endoscopes, to access the surgical site through small incisions or natural body openings. These instruments are equipped with cameras and lights, providing surgeons with a clear view of the internal structures and enabling precise maneuvers. MIS offers numerous benefits, including reduced post-operative pain, shorter hospital stays, faster recovery times, and smaller scars. As a result, it has become highly preferred across the healthcare sector to allow patients to undergo complex procedures with less trauma and improved outcomes.

United States Minimally Invasive Surgery Market Trends:

The rising awareness about the numerous advantages offered by minimally invasive surgeries, such as less blood loss, reduced pain, lower risk of infection, and faster recovery, has fueled their popularity among patients, primarily driving the market growth in the United States. Concurrent with this, cost savings associated with MIS is creating a positive outlook for market expansion. In addition to this, continuous advancements in surgical instruments, imaging technologies, and robotic systems are presenting remunerative growth opportunities for the market. Besides this, the expanding integration of robotics and artificial intelligence (AI) has enhanced the precision and dexterity of MIS procedures, enabling surgeons to perform intricate surgeries with improved accuracy and efficiency. Moreover, the development of innovative tools and techniques, such as single-incision laparoscopy and natural orifice transluminal endoscopic surgery (NOTES), are aiding in market expansion. Furthermore, the rising incidences of various chronic diseases, such as cardiovascular disorders (CVD), cancer, and gastrointestinal conditions, have led to a surge in demand for minimally invasive treatment options, thus acting as another significant contributor to the market growth. Other factors, such as the expanding geriatric population and the associated increase in age-related diseases, are aiding in market expansion. Looking forward, the market value is projected to reach US$ 35.3 Billion by 2032, expanding at a CAGR of 3.93% during 2024-2032.

Market Summary:

• Based on the product type, the market is divided into surgical, laparoscopy, and monitoring and visualization devices.
• On the basis of the application, the market has been segregated into bariatric, breast, cardiac, cosmetic, gastrointestinal, gynecological, orthopedics and spine, thoracic, and other surgeries.
• Based on the end user, the market is categorized into hospitals, clinics, and others.
• On a regional basis, the market has been segmented into Northeast, Midwest, South, and West.
• The competitive landscape of the industry has also been examined, covering the competitive structure and key player profiles.

Report Scope:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800